Niva Bupa Health Insurance Company Ltd

Q4 FY25Insurance

Niva Bupa Health Insurance Company Q4 FY25 earnings call: Revenue & Margins

Q4 FY25 earnings call: what management guided on revenue, margins and order book.

Price₹83

Market cap₹16.2K Cr

P/E92.9

Updated23 Aug 2026

Read4 min read

The short version

The company achieved a 32% growth in Gross Written Premium (GWP) on a like-to-like basis in FY25. Niva Bupa reported a strong PAT growth of 91% under IFRS, rising from Rs.106 crores in FY24 to Rs.203 crores in FY25.

From Niva Bupa Health Insurance Company Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

The company achieved a 32% growth in Gross Written Premium (GWP) on a like-to-like basis in FY25.
Retail lives covered grew by around 18% in FY25 compared to FY24.
Group health (including employer-employee and loan-attached products) has grown faster than retail business with overall growth around 32%.
The company continues to expand its distribution network, adding 8,000 agents and 30 new distribution partners in the last quarter.
Launch of the new product "Rise" targets the large unserved middle and lower-middle-class segment, expected to drive new customer additions.
The Preferred Provider Network is scaling up, now covering 40 cities and nearly 600 hospitals, enhancing value delivery to customers.

2 more points from Niva Bupa Health Insurance Company Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

Niva Bupa reported a strong PAT growth of 91% under IFRS, rising from Rs.106 crores in FY24 to Rs.203 crores in FY25.
Profit under iGAAP also rose significantly by 161%, from Rs.82 crores to Rs.214 crores in FY25.
The company improved its combined ratio on a like-to-like basis to 96.1% in FY25, showing better profitability potential.
Expense of management is on a downward trajectory, improving by 190 bps each year, currently at 37.4%, with a confident glide path to meet regulatory targets (~35.5%).
Continued growth in retail lives (+18%) and GWP (32%) supports earnings momentum.
Emphasis on disciplined underwriting, pricing adjustments, and fraud detection is expected to sustain profitability.

2 more points from Niva Bupa Health Insurance Company Ltd's call on margins

Pro opens every point from 15K+ earnings calls

See what Niva Bupa Health Insurance Company Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

The provided pages of the Niva Bupa Health Insurance Company Limited document do not explicitly mention any current or future capex, capital investment, or strategic investment plans. The information mainly covers financial results, growth metrics, claims management, product strategy, hospital network, and discussions around market dynamics and risk management. Key highlights related to investment from the transcript include: - Equity fundraise as part of IPO increased Assets Under Management (AUM) (Page 10). - Investment book primarily consists of debt with negligible equity exposure in NIFTY ETF recently (Page 8). - No specific mention of future capex or strategic investments disclosed during the Q4 FY25 call. Therefore, no detailed disclosures or plans related to capex or strategic investments are mentioned in the available pages.

Top-ranked in Insurance

Ranked on what management guided this quarter

Guidance-ranked

1Max Financial Services Ltd₹44.7K Cr

Rev 2Mar 3

2Medi Assist Healthcare Services Ltd₹2.3K Cr

Rev 2Mar 3

3₹1.2L Cr

Rev 3Mar 3

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

The document does not mention any current or planned future fundraising through debt or equity by Niva Bupa Health Insurance Company Limited.
The only related information is a mention of a primary capital raise as part of their IPO, which contributed to AUM growth, but no ongoing or future fundraising is indicated.
The investment book is currently almost entirely debt, with negligible recent investment in NIFTY ETF, but this relates to investment strategy, not fundraising.
No explicit plans or announcements about new debt or equity fundraising are discussed in the provided transcript.

See what Niva Bupa Health Insurance Company Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The provided document does not contain any information related to current or expected order book or pending orders for Niva Bupa Health Insurance Company Limited. The content predominantly covers discussions on claims ratio, customer demographics, product design, risk selection, hospital network, expense management, medical inflation, claims settlement ratios, and business growth metrics. No data or references to order books or pending orders are mentioned in the text on page 17 or in the related transcript excerpts. If you have any other questions or need information on a different topic from the document, please feel free to ask.

Niva Bupa Health Insurance Company Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss

Dec 2024Q3 FY25

Mar 2025Q4 FY25

Jun 2025Q1 FY26

Sep 2025Q2 FY26

Dec 2025Q3 FY26

Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹2.1K Cr, net profit ₹345 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Niva Bupa Health Insurance Company Ltd's management said in earlier quarters

Others in Insurance this season

Max Financial Services Ltd (Q4 FY25)
Individual adjusted first year premium grew 20% in FY '25, surpassing private sector growth of 15% and industry growth of 10%. Key concall takeaways from Max…
ICICI Lombard (Q4 FY25)
Focus on profitable growth with a strong emphasis on driving Return on Equity (ROE) between 16% to 20% for sustainable value creation. Key concall takeaways…
Medi Assist Healthcare Services Ltd (Q4 FY25)
Growth driven by expansion in both group and retail segments, with group premiums growing 12.4% FY '24 to FY '25 vs industry 10.5%, and retail premiums growing…

Compare:vs Life Insurance vs SBI Life Insurance Company Ltd vs HDFC Life Insur.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Niva Bupa Health Insurance Company Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Niva Bupa Health Insurance Company Ltd Q4 FY25 results?

What is Niva Bupa Health Insurance Company Ltd share price analysis?

Niva Bupa Health Insurance Company Ltd currently shows a neutral. The stock trades at a P/E of 92.9 with a market cap of ₹16,188 Cr. Investors should review the full earnings analysis for detailed insights.

Is Niva Bupa Health Insurance Company Ltd planning capital expenditure?

The provided pages of the Niva Bupa Health Insurance Company Limited document do not explicitly mention any current or future capex, capital investment, or strategic investment plans.

Keep Niva Bupa Health Insurance Company Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.